Table of Contents
Is CTMX a buy?
CytomX Therapeutics Inc (NASDAQ:CTMX) The 9 analysts offering 12-month price forecasts for CytomX Therapeutics Inc have a median target of 3.50, with a high estimate of 11.00 and a low estimate of 1.50. The median estimate represents a +171.32% increase from the last price of 1.29.
Is CNTX a buy?
According to the issued ratings of 2 analysts in the last year, the consensus rating for Context Therapeutics stock is Buy based on the current 2 buy ratings for CNTX. The average twelve-month price target for Context Therapeutics is $8.00 with a high price target of $10.00 and a low price target of $6.00.
What happened to Cytori Therapeutics?
Cytori Will Become Plus Therapeutics, Inc. Cytori Will Become Plus Therapeutics, Inc.
Is CytomX a good stock to Buy?
CytomX Therapeutics has received a consensus rating of Buy. The company’s average rating score is 3.00, and is based on 7 buy ratings, no hold ratings, and no sell ratings.
Why is CytomX stock dropping?
The steep decline came after the company announced disappointing preliminary results from a phase 2 study evaluating CX-2029 in treating patients with either advanced squamous non-small cell lung cancer (sqNSCLC) or head and neck squamous cell carcinoma (HNSCC).
Why is Cytomx stock dropping?
Should I buy Cytomx stock?
Is Cytomx Therapeutics Stock a good buy in 2022, according to Wall Street analysts? The consensus among 5 Wall Street analysts covering (NASDAQ: CTMX) stock is to Strong Buy CTMX stock.
Is CytomX a public company?
CytomX Therapeutics Announces Pricing of $100 Million Public Offering of Common Stock.
Is CytomX a good stock to buy?
When did CytomX go public?
CytomX’s common stock is traded under the ticker symbol “CTMX” on The NASDAQ Global Market. CytomX’s initial public offering was in September 2015.
What is Cytori Therapeutics'(cytx) stock price?
What is Cytori Therapeutics’ stock price today? One share of CYTX stock can currently be purchased for approximately $0.93. How much money does Cytori Therapeutics make? Cytori Therapeutics has a market capitalization of $20.64 million and generates $3.67 million in revenue each year.
What is Cytori Therapeutics’stock symbol?
What is Cytori Therapeutics’ stock symbol? Cytori Therapeutics trades on the NASDAQ under the ticker symbol “CYTX.” What is Cytori Therapeutics’ stock price today?
What is Cytori Therapeutics’return on equity?
Cytori Therapeutics had a negative trailing twelve-month return on equity of 272.70% and a negative net margin of 242.60%. View Cytori Therapeutics’ earnings history. When did Cytori Therapeutics’ stock split? How did Cytori Therapeutics’ stock split work? Cytori Therapeutics shares reverse split on Thursday, May 24th 2018.
Will Cytori Therapeutics (cytx) outperform or underperform the S&P 500 over the long term?
Vote “Outperform” if you believe CYTX will outperform the S&P 500 over the long term. Vote “Underperform” if you believe CYTX will underperform the S&P 500 over the long term. You may vote once every thirty days. Cytori Therapeutics does not currently pay a dividend. Cytori Therapeutics does not have a long track record of dividend growth.